130 related articles for article (PubMed ID: 2573443)
1. Indenolol, a beta-blocker with partial agonism at vascular beta-adrenoceptors.
Taddei S; Pedrinelli R; Salvetti A
Clin Pharmacol Ther; 1989 Nov; 46(5):560-5. PubMed ID: 2573443
[TBL] [Abstract][Full Text] [Related]
2. Renal and limb vasodilatation during acute beta-adrenoceptor blockade with indenolol.
Poggesi L; Bisi G; La Cava G; Sciagra R; Del Rosso A; Masotti G
J Clin Pharmacol; 1995 Feb; 35(2):176-81. PubMed ID: 7751429
[TBL] [Abstract][Full Text] [Related]
3. Effect of indenolol treatment on beta-adrenergic receptors of polymorphonucleates in essential hypertension.
Corradi L; Groothold G; Venco A; Mailland F; Negri F; Grandi A; Barzizza F; Finardi G
J Hypertens Suppl; 1986 Dec; 4(6):S137-40. PubMed ID: 2886569
[TBL] [Abstract][Full Text] [Related]
4. Acute effect of indenolol on systemic arterial pressure and heart rate in the rat.
Zuccari G; Falcone A; Turba C
Pharmacol Res Commun; 1986 Feb; 18(2):137-47. PubMed ID: 2871567
[TBL] [Abstract][Full Text] [Related]
5. Dose-response studies of indenolol, a beta adrenoceptor blocker.
Okupa FE; Daneshmend TK; Shrosbree E; Roberts CJ
Clin Pharmacol Ther; 1981 Apr; 29(4):434-9. PubMed ID: 6110504
[TBL] [Abstract][Full Text] [Related]
6. Acute and long-term haemodynamic effects of propranolol and indenolol in hypertension.
Malacco E; Mailland F; Bosisio E; Meroni R; Dagani R; Renesto E; Bevilacqua M
Eur J Clin Pharmacol; 1986; 30(2):157-60. PubMed ID: 3709639
[TBL] [Abstract][Full Text] [Related]
7. Effects of indenolol on blood pressure, lower limb blood flow, adrenergic reflexes, and plasma renin activity.
Poggesi L; Masotti G; Boddi M; Neri Serneri GG
Clin Pharmacol Ther; 1987 Mar; 41(3):344-50. PubMed ID: 2880689
[TBL] [Abstract][Full Text] [Related]
8. Effects of prolonged administration of indenolol in hypertensive rats.
Kato H; Kurihara J; Takata Y; Kunugi H; Miyajima Y
Arch Int Pharmacodyn Ther; 1983 Jul; 264(1):82-95. PubMed ID: 6138007
[TBL] [Abstract][Full Text] [Related]
9. Acute effect of indenolol on human airways.
Zanon P; Bruschi C; Cerveri I; Rossi A; Karitinos P; Pamparana F
Eur J Clin Pharmacol; 1985; 29(3):287-92. PubMed ID: 2866966
[TBL] [Abstract][Full Text] [Related]
10. Comparison of a vasodilating beta-blocker and a cardioselective beta-blocker in long-term treatment of hypertension: a European multicentre study.
Ambrosioni E; Birkenhäger W; De Leeuw PW; Dal Palù C; Demanet JC; Groothold G; Libretti A; Mailland F; Malacco E; Poli A
J Hypertens Suppl; 1989 Dec; 7(6):S266-7. PubMed ID: 2576667
[TBL] [Abstract][Full Text] [Related]
11. Clinical pharmacology of vasodilatory beta-blocking drugs.
Shanks RG
Am Heart J; 1991 Mar; 121(3 Pt 2):1006-11. PubMed ID: 1671724
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the antifibrillatory activity of fluorinated derivatives of indenolol and nadolol in isolated rabbit and rat hearts: comparison with propranolol.
Almotrefi AA; Aboul-Enein HY; Premkumar LS
Arch Int Pharmacodyn Ther; 1989; 301():122-30. PubMed ID: 2576192
[TBL] [Abstract][Full Text] [Related]
13. Beta-blockade antagonism of tyramine-induced rise in blood pressure.
Colombo F; Sega R; Mailland F; Rigo R; Palvarini L; Libretti A
Eur J Clin Pharmacol; 1988; 34(3):263-6. PubMed ID: 2899510
[TBL] [Abstract][Full Text] [Related]
14. Intrinsic sympathomimetic activity of (-)-pindolol mediated through a (-)-propranolol-resistant site of the beta1-adrenoceptor in human atrium and recombinant receptors.
Joseph SS; Lynham JA; Molenaar P; Grace AA; Colledge WH; Kaumann AJ
Naunyn Schmiedebergs Arch Pharmacol; 2003 Dec; 368(6):496-503. PubMed ID: 14608456
[TBL] [Abstract][Full Text] [Related]
15. Effects of betaxolol, propranolol, and atenolol on isoproterenol-induced beta-adrenoceptor responses.
Riddell JG; Shanks RG
Clin Pharmacol Ther; 1985 Nov; 38(5):554-9. PubMed ID: 2865028
[TBL] [Abstract][Full Text] [Related]
16. Indenolol in hypertension.
Sega R; Mailland F; Damiani E; Groothold G; Libretti A
Clin Pharmacol Ther; 1983 Mar; 33(3):289-93. PubMed ID: 6337761
[TBL] [Abstract][Full Text] [Related]
17. Effect of carteolol, indenolol and metoprolol on the thyroid hormone of hyperthyroid patients.
Yamamoto M; Sakurada T; Yoshida K; Kaise K; Kaise N; Fukazawa H; Suzuki M; Nomura T; Itagaki Y; Saito S
Tohoku J Exp Med; 1985 Aug; 146(4):385-90. PubMed ID: 2866611
[TBL] [Abstract][Full Text] [Related]
18. Dose difference in beta-adrenergic blockers with intrinsic sympathomimetic action to block beta-adrenoceptors and induce sympathomimetic action.
Takayanagi I; Ogishima M; Koike K; Hisayama T; Hayashida M; Fujii M
Gen Pharmacol; 1989; 20(4):417-9. PubMed ID: 2568966
[TBL] [Abstract][Full Text] [Related]
19. Selectivity of the intrinsic sympathomimetic activity of the beta-adrenergic blocking drug bucindolol.
Leff AR; Garrity ER; Munoz NM; Tallet J; Cavigelli M; Deitchman D; Rajfer SI
J Cardiovasc Pharmacol; 1984; 6(5):859-66. PubMed ID: 6209492
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
Hicks PE; Cavero I; Manoury P; Lefevre-Borg F; Langer SZ
J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
